AGP Picks
View all

VersaWell to present UriGent at New York Venture Summit

7 hours ago
VersaWell to present UriGent at New York Venture Summit
By AI, Created 06:36 UTC, Nov 17, 2026, AGP -

VersaWell will pitch its UriGent bedside portable urinal at the 2026 New York Venture Summit on Nov. 18-19 at the Javits Center in New York City. The appearance puts the startup in front of investors as it looks to grow adoption across homes, care facilities and urology practices.

Why it matters: - VersaWell gets a shot at investor attention at one of the country’s marquee startup gatherings. - The company is using the summit to promote UriGent, a bedside portable urinal aimed at reducing nighttime trips to the bathroom and the fall risk that comes with them. - The product also targets caregivers, assisted living facilities, nursing homes and urology practices.

What happened: - VersaWell said it was selected to present at the 2026 New York Venture Summit on Nov. 18-19 at the Javits Center in New York City. - The event is hosted by youngStartup Ventures. - VersaWell CEO and President Eric Ankerud will present the UriGent Bedside Portable Urinal to potential investors.

The details: - The summit will feature 190 top innovators across sectors. - Presenting companies were chosen by the youngStartup Ventures selection committee. - The audience is expected to include venture capitalists, corporate investors, angel networks and industry leaders. - The summit will also include venture panels, roundtables and networking sessions. - VersaWell was founded in 2025. - The company says it launched UriGent commercially in 2026. - VersaWell describes UriGent as a product designed to improve safety and independence for men concerned about nighttime falls.

Between the lines: - A summit presentation gives VersaWell a way to test investor interest in a niche healthcare product that blends consumer convenience with care-facility use cases. - The pitch suggests the company is trying to position UriGent as both a daily-use product and a tool for reducing risk in older or assisted-living populations.

What's next: - VersaWell will present at the summit and meet with investors during the two-day event. - Any funding, partnerships or commercial expansion would likely follow from that outreach.

The bottom line: - VersaWell is using a high-visibility investor event to push UriGent into the market’s spotlight and seek backing for growth.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Health Professional Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Professional Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.